Emphysema Completed Phase 4 Trials for Roflumilast (DB01656)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03073798The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic BronchitisTreatment